Estimated Control Closed Transaction verified Breath FresheningConsumerMouthwashOral CareOral Hygiene

TheraBreath acquired by Church & Dwight

Church & Dwight acquired TheraBreath, an US oral care brand on Nov 29, 2021. The transaction value is shown as USD 580m. The current comp implies EV / revenue of 4.95x.

Transaction summary

Target
TheraBreath
Acquirer
Church & Dwight
Seller
-
Announced
2021-11-29
Geography
United States
Tags
Breath FresheningConsumerMouthwashOral CareOral Hygiene
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-07-13

Value and multiples

Price / value

USD 580M

Consideration | USD

Basis: Public source

EV / revenue

4.95x

Period: Forward 2022

Basis: Derived from source data

EV / EBITDA

13.8x

EBITDA basis not stated

Basis: Derived from source data

Basis

  • USD 580m consideration is treated as publicly disclosed or derived directly from public source data.
  • EV / revenue is recorded as 4.95x. The stored USD 580m value and USD 100m revenue imply 5.8x; the rounded source inputs are retained with this variance disclosed.
  • Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
  • EV / EBITDA is recorded as 13.8x. The stored USD 580m value and USD 36.0m EBITDA imply 16.1x; the rounded source inputs are retained with this variance disclosed.

Other reviewed estimates

Transaction comps can involve reported or estimated figures from different sources. FundComb uses the values above as the current canonical comp, while preserving prior reviewed estimates below for context.

Revenue and EBITDA multiples are from pasted spreadsheet row; public web evidence supplied verifies transaction and headline value but not these multiples.
EV / revenue 4.5x | EV / EBITDA 18.3x

Source summary

Church and Dwight Acquires TheraBreath® Brand for $580 Million

Estimated

Church & Dwight announced the TheraBreath acquisition for $580 million, noted an $85 million cash tax shield, and provided 2022 projected net sales and adjusted EBITDA for the brand.

Open source